Search Results | MSF Science Portal

Journal Article

|

Review

Mathu R, Diago-Navarro E, Lynch E, Degail MA, Ousley J, et al.

2024-12-26 • JAC-Antimicrobial Resistance

INTRODUCTION

Despite global surveillance efforts, antibiotic resistance (ABR) is difficult to address in low- and middle-income countries (LMICs). In the absenc...

Journal Article

|

Research

Legros D, Fournier C, Gastellu-Etchegorry M, Maiso F, Szumilin E

1999-07-01 • Bulletin de la Société de Pathologie Exotique

The failure rate of melarsoprol after treatment of late stage cases of Human African Trypanosomiasis (HAT) is usually under 7%, even though the drug has been used for such treatment over...

Journal Article

|

Research

Legros D, Ollivier G, Gastellu-Etchegorry M, Paquet C, Burri C, et al.

2002-07-01 • Lancet Infectious Diseases

Human African trypanosomiasis re-emerged in the 1980s. However, little progress has been made in the treatment of this disease over the past decades. The first-line treatment for second-...

Journal Article

|

Research

Porter JDH, Gastellu-Etchegorry M, Navarre I, Lungu G, Moren A

1990-12-01 • International Journal of Epidemiology

Between November 1988 and January 1989, measles outbreaks occurred in 11 Mozambican refugee camps in Malawi with five camps principally affected. A total of 1214 cases were reported. Des...

Science Portal

Antibiotic resistance in the Middle East and Southern Asia: a systematic review and meta-analysis

Therapeutic Failure of Melarsoprol Among Patients Treated for Late Stage T.b. Gambiense Human African Trypanosomiasis in Uganda

Treatment of human African trypanosomiasis--present situation and needs for research and development

Measles outbreaks in the Mozambican refugee camps in Malawi: the continued need for an effective vaccine